Full text
PDFPage 938

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brignola C., Campieri M., Bazzocchi G., Farruggia P., Tragnone A., Lanfranchi G. A. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology. 1986 Dec;91(6):1490–1494. doi: 10.1016/0016-5085(86)90206-4. [DOI] [PubMed] [Google Scholar]
- Brignola C., De Simone G., Belloli C., Iannone P., Belluzzi A., Gionchetti P., Campieri M., Barbara L. Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration. Aliment Pharmacol Ther. 1994 Aug;8(4):465–468. doi: 10.1111/j.1365-2036.1994.tb00316.x. [DOI] [PubMed] [Google Scholar]
- Landi B., Anh T. N., Cortot A., Soule J. C., Rene E., Gendre J. P., Bories P., See A., Metman E. H., Florent C. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology. 1992 May;102(5):1647–1653. doi: 10.1016/0016-5085(92)91725-j. [DOI] [PubMed] [Google Scholar]
- Sahmoud T., Hoctin-Boes G., Modigliani R., Bitoun A., Colombel J. F., Soule J. C., Florent C., Gendre J. P., Lerebours E., Sylvester R. Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut. 1995 Dec;37(6):811–818. doi: 10.1136/gut.37.6.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
